Skip to content

Application of digital pulmonary rehabilitation therapy for chronic obstructive pulmonary disease - applicability evaluation

Application of digital pulmonary rehabilitation therapy for chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110097
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable chronic obstructive pulmonary disease

Interventions

Test group:Using apps and portable lung rehabilitation devices

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed with COPD, and the lung function was GOLD1-3 grade; 2. Age 45-70 years old; 3. The patients have a smart phone, can use the app skillfully; 4. Willing to follow up and sign informed consent;

Exclusion criteria

Exclusion criteria: 1. They suffer from bronchial asthma, bronchiectasis, tuberculosis of the lungs, thoracic deformity, extreme weakness, impaired vision or balance; 2. They suffer from malignant tumors, liver and kidney failure, osteoarthropathy and other diseases that cause limb movement disorders; 3. Unstable angina attack within one month, acute myocardial infarction within six months, severe arrhythmia, cardiac insufficiency, unsatisfactory blood pressure control in hypertensive patients (high pressure >140mmHg and/or low pressure >90mmHg); 4. Cognition impairment; 5. Combined respiratory failure; 6. The expected survival time is less than 1 year;

Design outcomes

Primary

MeasureTime frame
The incidence of acute exacerbation and readmission rate of patients within one month;

Secondary

MeasureTime frame
Applicability evaluation indicators (effectiveness, utilization efficiency, satisfaction, compliance);Symptom score, depression and anxiety score, quality of life score, 6-minute walk distance, lung function;

Countries

China

Contacts

Public ContactLiang Lirong

Beijing Chaoyang Hospital, Capital Medical University

llrcruie@163.com+86 10 85231547

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026